Search research articles
Contact Us
Filters
Showing results (141-150 of 301) with videos related to
Page
of 31
Sort By:
Alzheimer Disease and Associated Disorders
|
July 2, 2009
Lethality of Alzheimer disease and its impact on nursing home placement
Henry Michael Arrighi, Peter J Neumann, Ivan M Lieberburg, et al.
Pharmacoeconomics
|
April 6, 2004
How often do sensitivity analyses for economic parameters change cost-utility analysis conclusions?
Bruce R Schackman, Heather Taffet Gold, Patricia W Stone, et al.
Health Policy (Amsterdam, Netherlands)
|
February 20, 2013
What can we learn from the U.S. expanded end-stage renal disease bundle?
James D Chambers, Daniel E Weiner, Sarah K Bliss, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 12, 2013
Potentially avoidable hospitalizations among Medicare beneficiaries with Alzheimer's disease and related disorders
Pei-Jung Lin, Howard M Fillit, Joshua T Cohen, et al.
Journal of Managed Care & Specialty Pharmacy
|
November 28, 2018
Discrepancies Between FDA-Required Labeling and Evidence that Payers Cite in Drug Coverage Policies
James D Chambers, Elle F Pope, Colby L Wilkinson, et al.
Health Affairs (Project Hope)
|
October 8, 2014
Despite high costs, specialty drugs may offer value for money comparable to that of traditional drugs
James D Chambers, Teja Thorat, Junhee Pyo, et al.
Pharmacoeconomics
|
May 9, 2019
Publication of Decision Model Source Code: Attitudes of Health Economics Authors
Joanna Emerson, Rachel Bacon, Alma Kent, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 12, 2025
Cost-Effectiveness of the 15 Drugs Selected for Initial Price Applicability Year 2027 by Centers for Medicare and Medicaid Services Drug Price Negotiation Program
Feng Xie, Ting Zhou, Yue Ma, et al.
Managed Care Interface
|
August 9, 2006
The economic burden of intracerebral hemorrhage: evidence from managed care
Mason W Russell, Luke Boulanger, Ashish V Joshi, et al.
Journal of the American Geriatrics Society
|
June 14, 2016
Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After Diagnosis
Pei-Jung Lin, Yue Zhong, Howard M Fillit, et al.
Page
of 31
Search research articles
Search
Showing results (141-150 of 301) with videos related to
Sort By:
Page
of 31
Alzheimer Disease and Associated Disorders
|
July 2, 2009
Lethality of Alzheimer disease and its impact on nursing home placement
Henry Michael Arrighi, Peter J Neumann, Ivan M Lieberburg, et al.
Pharmacoeconomics
|
April 6, 2004
How often do sensitivity analyses for economic parameters change cost-utility analysis conclusions?
Bruce R Schackman, Heather Taffet Gold, Patricia W Stone, et al.
Health Policy (Amsterdam, Netherlands)
|
February 20, 2013
What can we learn from the U.S. expanded end-stage renal disease bundle?
James D Chambers, Daniel E Weiner, Sarah K Bliss, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 12, 2013
Potentially avoidable hospitalizations among Medicare beneficiaries with Alzheimer's disease and related disorders
Pei-Jung Lin, Howard M Fillit, Joshua T Cohen, et al.
Journal of Managed Care & Specialty Pharmacy
|
November 28, 2018
Discrepancies Between FDA-Required Labeling and Evidence that Payers Cite in Drug Coverage Policies
James D Chambers, Elle F Pope, Colby L Wilkinson, et al.
Health Affairs (Project Hope)
|
October 8, 2014
Despite high costs, specialty drugs may offer value for money comparable to that of traditional drugs
James D Chambers, Teja Thorat, Junhee Pyo, et al.
Pharmacoeconomics
|
May 9, 2019
Publication of Decision Model Source Code: Attitudes of Health Economics Authors
Joanna Emerson, Rachel Bacon, Alma Kent, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 12, 2025
Cost-Effectiveness of the 15 Drugs Selected for Initial Price Applicability Year 2027 by Centers for Medicare and Medicaid Services Drug Price Negotiation Program
Feng Xie, Ting Zhou, Yue Ma, et al.
Managed Care Interface
|
August 9, 2006
The economic burden of intracerebral hemorrhage: evidence from managed care
Mason W Russell, Luke Boulanger, Ashish V Joshi, et al.
Journal of the American Geriatrics Society
|
June 14, 2016
Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After Diagnosis
Pei-Jung Lin, Yue Zhong, Howard M Fillit, et al.
Page
of 31